Ambalal Sarabhai Enterprises Ltd.
BSE: 500009 | Sector: Health care |
NSE: AMBASARABH | ISIN Code: INE432A01017 |
BSE 00:00 | 07 Feb | 23.10 |
-0.10 (-0.43%) |
OPEN
23.70 |
HIGH
23.70 |
LOW
22.90 |
NSE 05:30 | 01 Jan | Ambalal Sarabhai Enterprises Ltd |
OPEN | 23.70 |
PREVIOUS CLOSE | 23.20 |
VOLUME | 42579 |
52-Week high | 40.35 |
52-Week low | 22.90 |
P/E | 35.54 |
Mkt Cap.(Rs cr) | 177 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Ambalal Sarabhai Enterprises Ltd. (AMBASARABH) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 1005.65 | -17.85 | -1.74 | 15585.98 |
Dr Reddy's Labs | 4441.90 | 91.85 | 2.11 | 14405.20 |
Cipla | 1031.35 | 1.60 | 0.16 | 13091.79 |
Lupin | 751.90 | 6.85 | 0.92 | 11771.67 |
Aurobindo Pharma | 418.65 | 3.20 | 0.77 | 11287.14 |
Divi's Lab. | 2749.20 | -28.95 | -1.04 | 8879.82 |
Alkem Lab | 3065.50 | -3.75 | -0.12 | 8829.81 |
Glenmark Pharma. | 392.40 | -6.80 | -1.70 | 8141.58 |
Zydus Lifesci. | 479.40 | 9.25 | 1.97 | 7981.90 |
Torrent Pharma. | 1535.05 | -4.75 | -0.31 | 6742.32 |
Apollo Hospitals | 4317.85 | 0.60 | 0.01 | 6098.30 |
Ipca Labs. | 860.30 | 1.55 | 0.18 | 5399.36 |
Alembic Pharma | 524.60 | -3.35 | -0.63 | 5035.41 |
Abbott India | 20957.80 | 76.45 | 0.37 | 4919.27 |
Laurus Labs | 330.30 | -3.80 | -1.14 | 4707.04 |
Gland Pharma | 1308.80 | 134.70 | 11.47 | 4400.71 |
Granules India | 285.05 | -3.25 | -1.13 | 3238.44 |
Glaxosmi. Pharma | 1239.65 | 1.15 | 0.09 | 3217.51 |
Ajanta Pharma | 1187.70 | 23.65 | 2.03 | 3140.64 |
Piramal Pharma | 98.05 | -2.40 | -2.39 | 3094.95 |
Quick Links for Ambalal Sarabhai Enterprises:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices